Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 24, 2018
A new cell based profiling service for drug discovery from Reaction Biology Corporation (RBC) and Promega Corporation will allow more researchers to better prioritize compounds earlier.
read more
Reaction Biology Corporation (RBC) and PharmaCore Labs (PCL) announced a joint collaboration agreement in China.
read more
Reaction Biology Corporation has received a subcontract from Leidos Biomedical Research, which operates the Frederick National Laboratory for Cancer Research for the National Cancer Institute.
read more
Friday, December 02, 2022
Reaction Biology Corporation announced that the Company has closed on a definitive agreement for Reaction to acquire Bioassay Labor für biologische Analytik GmbH ("Bioassay"), including its wholly-owned subsidiary, Peptide Specialty Laboratories GmbH...
read more
Tuesday, January 31, 2017
ReachBio Research Labs has announced the launch of their new drug development platform, cellPrism®. The platform is designed to offer biotechnology and pharmaceutical companies a spectrum of customized in vitro assays to assess and evaluate potential...
read more
Monday, November 04, 2019
Raybow Pharmaceutical, a global pharmaceutical chemistry services provider, has acquired US-based PharmAgra Labs.
read more
Thursday, February 18, 2021
Raremark has announced it is rebranding as Xperiome to better refine and enhance its offering to patients and the pharma industry as it enters into its next phase of growth.
read more
Raremark® has launched its patient-powered knowledge platform Xperiome™ to help the pharmaceutical industry deliver innovative new therapies faster and smarter.
read more
Thursday, September 24, 2020
Raremark has implemented a new executive team to drive the commercial vision and future growth of the company.
read more
Tuesday, February 02, 2021
Raremark has named Caroline O’Connor as its new Chief Commercial Officer to drive the business forward.
read more
Wednesday, January 20, 2021
Raremark has appointed Nicki Grundy as Chief Financial Officer to support the accelerated levels of growth the company is experiencing.
read more
Wednesday, October 04, 2023
Rarebase, a platform drug development biotechnology company that is revolutionizing discovering and developing medicines at unprecedented speed, scale, and capital efficiency, announced that Chris Moxham, Ph.D., President and Chief Scientific Officer...
read more
Monday, February 24, 2020
TriNetX announced Raremark, a patient data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to the community.
read more
Thursday, January 25, 2018
Science Exchange announced a partnership with Rapid Novor to offer its REmAb Antibody Protein Sequencing Services to scientists around the world using Science Exchange’s R&D platform.
read more
Wednesday, August 26, 2020
Rain Therapeutics has announced the signing of an agreement of a Drexel research program for small molecule inhibitors of RAD52.
read more